BBHC
NUVA

Brown Brothers Harriman & Co’s NuVasive, Inc. NUVA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$7K – 829
2017
Q1 		$7K Hold
100
– – ﹤0.01% 701
2016
Q4 		$7K Hold
100
– – ﹤0.01% 743
2016
Q3 		$7K Hold
100
– – ﹤0.01% 656
2016
Q2 		$6K Buy
+100
New +$5.41K ﹤0.01% 701

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Brown Brothers Harriman & Co's NUVA Position: Q2 2017 in Review

Brown Brothers Harriman & Co sold out of NuVasive, Inc. (NUVA) in Q2 2017, closing a stake of 100 shares — an estimated $7K sold.

Brown Brothers Harriman & Co first reported a position in NUVA in Q2 2016 and held it in 4 quarters. The position peaked at $7K in Q1 2017. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

  • Brown Brothers Harriman & Co reported no remaining NuVasive, Inc. position as of Q2 2017 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 100 NuVasive, Inc. shares in Q2 2017, an estimated $7K.
  • Brown Brothers Harriman & Co first reported a position in NuVasive, Inc. in Q2 2016 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's NuVasive, Inc. position peaked at $7K in Q1 2017.
  • 298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.